Coronavirus disease 2019 (COVID-19) emerged as viral pandemic in the year 2019 and surgical intervention was forced to be restricted during the pandemic. This study aims to compare the perioperative outcomes of surgeries for acute cholecystitis in the period following the COVID-19 pandemic. A retrospective analysis was conducted on the demographic and perioperative data of 246 cholecystectomy cases performed between June 2017 and November 2022. This analysis focused on comparing patient background and perioperative outcomes before and after the COVID-19 pandemic. As a result, prior to the pandemic, 72 emergency surgeries for acute cholecystitis were performed, compared with 174 cases following the COVID-19 pandemic onset. This increase, particularly in mild and moderate acute cholecystitis cases, led to a significant rise in the proportion of laparoscopic resections and a concurrent decrease in postoperative hospital stays. Our findings suggest a potential increase in acute cholecystitis cases at our hospital coinciding with the COVID-19 pandemic. Early laparoscopic cholecystectomy, when feasible within the medical system's capacity, can be an effective treatment strategy during the pandemic.
{"title":"Increase in Acute Cholecystitis and Laparoscopic Resection after COVID-19 Pandemic: A Japanese Single Center Experience.","authors":"Mineto Ohta, Rikiya Kanba, Masataka Kudo, Hiroyasu Nishimaki, Akane Mineyuki, Kenji Namiki","doi":"10.1620/tjem.2024.J054","DOIUrl":"10.1620/tjem.2024.J054","url":null,"abstract":"<p><p>Coronavirus disease 2019 (COVID-19) emerged as viral pandemic in the year 2019 and surgical intervention was forced to be restricted during the pandemic. This study aims to compare the perioperative outcomes of surgeries for acute cholecystitis in the period following the COVID-19 pandemic. A retrospective analysis was conducted on the demographic and perioperative data of 246 cholecystectomy cases performed between June 2017 and November 2022. This analysis focused on comparing patient background and perioperative outcomes before and after the COVID-19 pandemic. As a result, prior to the pandemic, 72 emergency surgeries for acute cholecystitis were performed, compared with 174 cases following the COVID-19 pandemic onset. This increase, particularly in mild and moderate acute cholecystitis cases, led to a significant rise in the proportion of laparoscopic resections and a concurrent decrease in postoperative hospital stays. Our findings suggest a potential increase in acute cholecystitis cases at our hospital coinciding with the COVID-19 pandemic. Early laparoscopic cholecystectomy, when feasible within the medical system's capacity, can be an effective treatment strategy during the pandemic.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"151-157"},"PeriodicalIF":1.7,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141459490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-25Epub Date: 2024-06-27DOI: 10.1620/tjem.2024.J050
Mengshi Chen, Bo Liu, Zhaoming Ding, Ruinan Sheng, Jiewu Zhang
Transient receptor potential canonical 1 (TRPC1) facilitates the proliferation, invasion, and metastasis of thyroid cancer cells through up-regulating vascular endothelial growth factor receptor 2 (VEGFR2), while its clinical role in papillary thyroid carcinoma (PTC) is unknown. This study intended to evaluate the prognostic value of TRPC1 and its correlation with VEGFR2 in PTC patients. In this retrospective study, tumor TRPC1 immunohistochemistry (IHC) score was evaluated in 287 PTC patients who underwent surgical resection and 30 thyroid benign lesion (TBL) patients. Moreover, 50 tumor tissue samples from PTC patients were randomly selected for VEGFR2 IHC score evaluation. Our study showed that tumor TRPC1 IHC score was increased in PTC patients versus TBL patients (P = 0.006). Meanwhile, tumor TRPC1 IHC score was related to extrathyroidal invasion (P = 0.028) and pathological node stage 1 (P = 0.011) in PTC patients. Tumor TRPC1 IHC score > 0 was not related to disease-free survival (DFS) or overall survival (OS) (both P > 0.05); however, tumor TRPC1 IHC score > 3 was linked with shortened DFS (P = 0.005) and OS (P = 0.020) in PTC patients. By time-dependent area under curve (AUC) analyses, tumor TRPC1 IHC score showed good values in estimating relapse and death risks over 7 years with all AUCs above 0.7. Furthermore, tumor TRPC1 IHC score > 3 independently predicted shorter DFS (hazard ratio = 2.948, P = 0.045), but not OS (P > 0.05) in PTC patients. Tumor TRPC1 IHC score was positively associated with tumor VEGFR2 IHC score in PTC patients (P = 0.010). Collectively, TRPC1 links with extrathyroidal and lymph node invasion, elevated disease relapse risk, and increased VEGFR2 in PTC patients.
{"title":"The Prognostic Significance of Transient Receptor Potential Canonical 1 and Its Association with Vascular Endothelial Growth Factor Receptor 2 in Papillary Thyroid Carcinoma Patients.","authors":"Mengshi Chen, Bo Liu, Zhaoming Ding, Ruinan Sheng, Jiewu Zhang","doi":"10.1620/tjem.2024.J050","DOIUrl":"10.1620/tjem.2024.J050","url":null,"abstract":"<p><p>Transient receptor potential canonical 1 (TRPC1) facilitates the proliferation, invasion, and metastasis of thyroid cancer cells through up-regulating vascular endothelial growth factor receptor 2 (VEGFR2), while its clinical role in papillary thyroid carcinoma (PTC) is unknown. This study intended to evaluate the prognostic value of TRPC1 and its correlation with VEGFR2 in PTC patients. In this retrospective study, tumor TRPC1 immunohistochemistry (IHC) score was evaluated in 287 PTC patients who underwent surgical resection and 30 thyroid benign lesion (TBL) patients. Moreover, 50 tumor tissue samples from PTC patients were randomly selected for VEGFR2 IHC score evaluation. Our study showed that tumor TRPC1 IHC score was increased in PTC patients versus TBL patients (P = 0.006). Meanwhile, tumor TRPC1 IHC score was related to extrathyroidal invasion (P = 0.028) and pathological node stage 1 (P = 0.011) in PTC patients. Tumor TRPC1 IHC score > 0 was not related to disease-free survival (DFS) or overall survival (OS) (both P > 0.05); however, tumor TRPC1 IHC score > 3 was linked with shortened DFS (P = 0.005) and OS (P = 0.020) in PTC patients. By time-dependent area under curve (AUC) analyses, tumor TRPC1 IHC score showed good values in estimating relapse and death risks over 7 years with all AUCs above 0.7. Furthermore, tumor TRPC1 IHC score > 3 independently predicted shorter DFS (hazard ratio = 2.948, P = 0.045), but not OS (P > 0.05) in PTC patients. Tumor TRPC1 IHC score was positively associated with tumor VEGFR2 IHC score in PTC patients (P = 0.010). Collectively, TRPC1 links with extrathyroidal and lymph node invasion, elevated disease relapse risk, and increased VEGFR2 in PTC patients.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"141-149"},"PeriodicalIF":1.7,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141459494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-25Epub Date: 2024-07-04DOI: 10.1620/tjem.2024.J060
Wei Wei, Ping Fu, Lei Ju, Li Chen, Hongyu Hui
Reminiscence therapy (RT) is an effective psychological intervention to address mental disorders in the elderly; however, it is insufficiently appraised in elderly postoperative cervical cancer patients complicated with anxiety or depression. Hence, this study aimed to explore the effect of RT-engaged care (RTEC) on this population. Totally, 112 elderly postoperative cervical cancer patients with anxiety or depression were enrolled in this single-center, randomized, controlled study, and randomized into RTEC group (N = 56) or usual care group (N = 56) for a 12-week intervention. Evaluations were performed at baseline and the 4 th week (W4), 8th week (W8), and 12th week (W12) after intervention initiation.Hospital anxiety and depression scale (HADS)-anxiety score at W12 (P = 0.028) as well as HADS-depression score at W8 (P = 0.028) and W12 (P = 0.017) were reduced in RTEC group compared to usual care group. However, the mini-mental state examination score at W4, W8, and W12 was not different between the two groups (all P > 0.050). Concerning quality of life (QoL), EuroQol 5-dimensions score at W12 was reduced in RTEC group than in usual care group (P = 0.010). Both quality of life questionnaire Core 30 (QLQ-C30) global-health-status score and QLQ-C30 function score at W8 and W12 were elevated in RTEC group compared to usual care group (all P < 0.050). Whereas no difference was seen in QLQ-C30 symptom score at these timepoints between the two groups (all P > 0.050). In conclusion, RTEC alleviates psychological burden and improves QoL in elderly postoperative cervical cancer patients with anxiety or depression, while the effect in enhancing cognitive function is not obvious.
{"title":"Reminiscence Therapy-Engaged Care Exhibits a Pleasing Effect on Attenuating Psychological Burden and Bolstering Quality of Life in Elderly Postoperative Cervical Cancer Patients with Anxiety or Depression.","authors":"Wei Wei, Ping Fu, Lei Ju, Li Chen, Hongyu Hui","doi":"10.1620/tjem.2024.J060","DOIUrl":"10.1620/tjem.2024.J060","url":null,"abstract":"<p><p>Reminiscence therapy (RT) is an effective psychological intervention to address mental disorders in the elderly; however, it is insufficiently appraised in elderly postoperative cervical cancer patients complicated with anxiety or depression. Hence, this study aimed to explore the effect of RT-engaged care (RTEC) on this population. Totally, 112 elderly postoperative cervical cancer patients with anxiety or depression were enrolled in this single-center, randomized, controlled study, and randomized into RTEC group (N = 56) or usual care group (N = 56) for a 12-week intervention. Evaluations were performed at baseline and the 4 <sup>th</sup> week (W4), 8<sup>th</sup> week (W8), and 12<sup>th</sup> week (W12) after intervention initiation.Hospital anxiety and depression scale (HADS)-anxiety score at W12 (P = 0.028) as well as HADS-depression score at W8 (P = 0.028) and W12 (P = 0.017) were reduced in RTEC group compared to usual care group. However, the mini-mental state examination score at W4, W8, and W12 was not different between the two groups (all P > 0.050). Concerning quality of life (QoL), EuroQol 5-dimensions score at W12 was reduced in RTEC group than in usual care group (P = 0.010). Both quality of life questionnaire Core 30 (QLQ-C30) global-health-status score and QLQ-C30 function score at W8 and W12 were elevated in RTEC group compared to usual care group (all P < 0.050). Whereas no difference was seen in QLQ-C30 symptom score at these timepoints between the two groups (all P > 0.050). In conclusion, RTEC alleviates psychological burden and improves QoL in elderly postoperative cervical cancer patients with anxiety or depression, while the effect in enhancing cognitive function is not obvious.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"131-139"},"PeriodicalIF":1.7,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-20Epub Date: 2024-07-04DOI: 10.1620/tjem.2024.J058
Qun Li, Jin-Juan Zhu
This study aimed to assess the diagnostic potential of microRNA-181 (miR-181) family members in oral biofluids, namely saliva and gingival crevicular fluid (GCF), as biomarkers for periodontitis severity. A cohort of 150 patients with periodontitis, including 82 with mild to moderate and 68 with advanced periodontitis, along with 90 healthy controls, were recruited. Analysis of miR-181 family expression using quantitative real-time polymerase chain reaction (qRT-PCR) revealed differential expression levels in oral biofluids among the study groups. Salivary miRNAs, particularly miR-181a, displayed significant discriminatory ability in distinguishing periodontitis patients from healthy controls and between different stages of periodontitis severity, with high sensitivity and moderate to high specificity. In GCF samples, miR-181a and miR-181b exhibited robust discriminatory ability, while miR-181c showed moderate discriminatory ability. Conversely, miR-181d demonstrated lower discriminatory power in both saliva and GCF. Additionally, combination diagnosis using miR-181 family showed superior performance compared to individual miRNAs. Furthermore, enzyme-linked immunosorbent assay (ELISA) analysis of inflammatory biomarkers (TNF-α, IL-6, and IL-1β) in GCF revealed elevated levels in periodontitis patients compared to healthy controls, with a further increase observed in advanced periodontitis. Spearman correlation analysis demonstrated a significant negative correlation between miR-181 family expression in GCF and inflammatory biomarker levels, indicating their potential role in modulating periodontal inflammation. Overall, these findings suggest that miR-181 family members in oral biofluids, particularly saliva, hold promise as diagnostic biomarkers for periodontitis severity. Additionally, their negative correlation with inflammatory biomarkers highlights their potential as modulators of periodontal inflammation, providing valuable insights into the pathogenesis of periodontitis.
{"title":"Expression Levels of miR-181 Family Members in Oral Biofluids as Biomarkers for Periodontitis Severity.","authors":"Qun Li, Jin-Juan Zhu","doi":"10.1620/tjem.2024.J058","DOIUrl":"10.1620/tjem.2024.J058","url":null,"abstract":"<p><p>This study aimed to assess the diagnostic potential of microRNA-181 (miR-181) family members in oral biofluids, namely saliva and gingival crevicular fluid (GCF), as biomarkers for periodontitis severity. A cohort of 150 patients with periodontitis, including 82 with mild to moderate and 68 with advanced periodontitis, along with 90 healthy controls, were recruited. Analysis of miR-181 family expression using quantitative real-time polymerase chain reaction (qRT-PCR) revealed differential expression levels in oral biofluids among the study groups. Salivary miRNAs, particularly miR-181a, displayed significant discriminatory ability in distinguishing periodontitis patients from healthy controls and between different stages of periodontitis severity, with high sensitivity and moderate to high specificity. In GCF samples, miR-181a and miR-181b exhibited robust discriminatory ability, while miR-181c showed moderate discriminatory ability. Conversely, miR-181d demonstrated lower discriminatory power in both saliva and GCF. Additionally, combination diagnosis using miR-181 family showed superior performance compared to individual miRNAs. Furthermore, enzyme-linked immunosorbent assay (ELISA) analysis of inflammatory biomarkers (TNF-α, IL-6, and IL-1β) in GCF revealed elevated levels in periodontitis patients compared to healthy controls, with a further increase observed in advanced periodontitis. Spearman correlation analysis demonstrated a significant negative correlation between miR-181 family expression in GCF and inflammatory biomarker levels, indicating their potential role in modulating periodontal inflammation. Overall, these findings suggest that miR-181 family members in oral biofluids, particularly saliva, hold promise as diagnostic biomarkers for periodontitis severity. Additionally, their negative correlation with inflammatory biomarkers highlights their potential as modulators of periodontal inflammation, providing valuable insights into the pathogenesis of periodontitis.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"121-130"},"PeriodicalIF":1.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The optimal immunosuppressive therapy for elderly patients with ulcerative colitis (UC) remains unclear. We aimed to evaluate clinical practice and prognosis in elderly patients with UC through comparing between those with elderly-onset UC (EOUC) and those with long-standing elderly UC (LEUC). In this retrospective single-center cohort study, we evaluated elderly patients with UC aged ≥ 60 in August 2022 through collecting medical record data from the time of diagnosis of UC until August 2022. The patients were divided into two groups based on age at disease onset: EOUC (age at onset, ≥ 60 years) and LEUC (age at onset, < 60 years). We assessed the cumulative rates of systemic steroid and molecular targeted drug (MTD) initiation, and colectomy. We enrolled 97 eligible patients (EOUC group, n = 30; LEUC group, n = 67). The cumulative rates of initiating systemic steroid (46% vs. 22% at 1 year, respectively; P = 0.002) and MTD (17% vs. 5% at 1 year, respectively; P = 0.002) were higher in the EOUC group than in the LEUC group. In multivariate analysis, elderly onset was significantly associated with systemic steroid (hazard ratio [HR] 2.74, 95% confidence interval [CI] 1.43-5.29; P = 0.003) and MTD (HR 2.76, 95% CI 1.30-5.87; P = 0.008) initiation. Cumulative colectomy rates did not differ significantly between the two groups. Patients with EOUC were initiated on systemic steroids and MTDs sooner following disease onset than patients with LEUC. Our findings suggest rapid progression and refractoriness in patients with EOUC.
{"title":"Differences in Clinical Practice and Disease Course Between Elderly-Onset and Long-Standing Elderly Ulcerative Colitis: A Single-Center Study in Japan.","authors":"Motoi Sawahashi, Rintaro Moroi, Yoichi Kakuta, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Hisashi Shiga, Atsushi Masamune","doi":"10.1620/tjem.2024.J063","DOIUrl":"10.1620/tjem.2024.J063","url":null,"abstract":"<p><p>The optimal immunosuppressive therapy for elderly patients with ulcerative colitis (UC) remains unclear. We aimed to evaluate clinical practice and prognosis in elderly patients with UC through comparing between those with elderly-onset UC (EOUC) and those with long-standing elderly UC (LEUC). In this retrospective single-center cohort study, we evaluated elderly patients with UC aged ≥ 60 in August 2022 through collecting medical record data from the time of diagnosis of UC until August 2022. The patients were divided into two groups based on age at disease onset: EOUC (age at onset, ≥ 60 years) and LEUC (age at onset, < 60 years). We assessed the cumulative rates of systemic steroid and molecular targeted drug (MTD) initiation, and colectomy. We enrolled 97 eligible patients (EOUC group, n = 30; LEUC group, n = 67). The cumulative rates of initiating systemic steroid (46% vs. 22% at 1 year, respectively; P = 0.002) and MTD (17% vs. 5% at 1 year, respectively; P = 0.002) were higher in the EOUC group than in the LEUC group. In multivariate analysis, elderly onset was significantly associated with systemic steroid (hazard ratio [HR] 2.74, 95% confidence interval [CI] 1.43-5.29; P = 0.003) and MTD (HR 2.76, 95% CI 1.30-5.87; P = 0.008) initiation. Cumulative colectomy rates did not differ significantly between the two groups. Patients with EOUC were initiated on systemic steroids and MTDs sooner following disease onset than patients with LEUC. Our findings suggest rapid progression and refractoriness in patients with EOUC.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"109-116"},"PeriodicalIF":1.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141580909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
An enlarging ground-glass nodule (GGN) in the lungs closely resembles the characteristic appearance of a well differentiated lung adenocarcinoma or adenocarcinoma in situ (AIS). Herein, we present an unusual case characterized by clinical features suggestive of AIS but pathologically confirmed as exhibiting pulmonary alveolar proteinosis (PAP)-like changes. Patients with enlarging pure GGNs warrant consideration for diagnostic and curative surgery. While a considerable proportion of such cases receives a pathological diagnosis of lung malignancy, it is imperative to consider alternative benign conditions in the differential diagnosis, such as PAP-like changes.
{"title":"Pulmonary Alveolar Proteinosis-Like Pathological Changes Mimicking Lung Adenocarcinoma in Situ.","authors":"Kazuki Hayasaka, Tomohiro Fujita, Shunsuke Eba, Nobuyuki Sato, Hidekachi Kurotaki, Chihiro Inoue","doi":"10.1620/tjem.2024.J064","DOIUrl":"10.1620/tjem.2024.J064","url":null,"abstract":"<p><p>An enlarging ground-glass nodule (GGN) in the lungs closely resembles the characteristic appearance of a well differentiated lung adenocarcinoma or adenocarcinoma in situ (AIS). Herein, we present an unusual case characterized by clinical features suggestive of AIS but pathologically confirmed as exhibiting pulmonary alveolar proteinosis (PAP)-like changes. Patients with enlarging pure GGNs warrant consideration for diagnostic and curative surgery. While a considerable proportion of such cases receives a pathological diagnosis of lung malignancy, it is imperative to consider alternative benign conditions in the differential diagnosis, such as PAP-like changes.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"117-120"},"PeriodicalIF":1.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141634627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Voice abuse, chronic cough, laryngeal surgery, and tracheal intubation may lead to injury and subsequent repair/remodeling in the vocal fold mucosa. Periostin is known to be involved in airway remodeling and is also associated with various otolaryngological diseases. D-β-aspartic acid is the major isomer of D-aspartic acid found in tissues of elderly individuals. In ischemic heart disease, increased CD31 expression has been observed around cardiomyocytes during remodeling, and endothelial proliferation has been reported at these sites. In this study, we investigated the expression and role of CD31, CD34, D-β-aspartic acid, and periostin in the formation of laryngeal granulation tissue. This retrospective study involved five patients who underwent surgical treatment for laryngeal granulation tissue. The expressions of CD31, CD34, D-β-aspartic acid, and periostin in surgical samples were investigated by immunohistochemistry. Histologically, the specimens showed inflammatory cell infiltration, fibrin exudation, fibrosis, and neovascularization, but no tumor cells. No stratified squamous epithelial covering was observed. The expression of periostin and D-β-aspartic acid was also observed in the specimens. CD31-positive cells (endothelial cells) and CD34-positive cells (progenitors of endothelial cells) were observed in the specimens. Our results indicate that the overexpression of CD31, CD34, D-β-aspartic acid, and periostin may play a role in the pathogenesis of laryngeal granulation tissue, and we speculate that D-β-aspartic acid and periostin could serve as novel biomarkers and therapeutic targets for laryngeal granulation tissue.
{"title":"Expression of Vascular and Tissue Repair Factors in Laryngeal Granulomas.","authors":"Yutaka Tateda, Ryoukichi Ikeda, Risako Kakuta, Kenji Izuhara, Takenori Ogawa, Kazue Ise, Hiroki Shimada, Keigo Murakami, Kazuhiro Murakami, Yasuhiro Nakamura, Yukio Katori, Nobuo Ohta","doi":"10.1620/tjem.2024.J056","DOIUrl":"10.1620/tjem.2024.J056","url":null,"abstract":"<p><p>Voice abuse, chronic cough, laryngeal surgery, and tracheal intubation may lead to injury and subsequent repair/remodeling in the vocal fold mucosa. Periostin is known to be involved in airway remodeling and is also associated with various otolaryngological diseases. D-β-aspartic acid is the major isomer of D-aspartic acid found in tissues of elderly individuals. In ischemic heart disease, increased CD31 expression has been observed around cardiomyocytes during remodeling, and endothelial proliferation has been reported at these sites. In this study, we investigated the expression and role of CD31, CD34, D-β-aspartic acid, and periostin in the formation of laryngeal granulation tissue. This retrospective study involved five patients who underwent surgical treatment for laryngeal granulation tissue. The expressions of CD31, CD34, D-β-aspartic acid, and periostin in surgical samples were investigated by immunohistochemistry. Histologically, the specimens showed inflammatory cell infiltration, fibrin exudation, fibrosis, and neovascularization, but no tumor cells. No stratified squamous epithelial covering was observed. The expression of periostin and D-β-aspartic acid was also observed in the specimens. CD31-positive cells (endothelial cells) and CD34-positive cells (progenitors of endothelial cells) were observed in the specimens. Our results indicate that the overexpression of CD31, CD34, D-β-aspartic acid, and periostin may play a role in the pathogenesis of laryngeal granulation tissue, and we speculate that D-β-aspartic acid and periostin could serve as novel biomarkers and therapeutic targets for laryngeal granulation tissue.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"93-99"},"PeriodicalIF":1.7,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141459442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}